In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings both on land and in air. The N1's exceptional reliability and strong performance enhance your confidence to provide seamless patient care during transport no matter intra or out of hospital. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. benevision-n1-fig2-1-pc BeneVision N1 as a Multi-Parameter Module Slide directly into the module slot or SMR of the N-Series monitor providing an expansive set of parameter measurements. When combined with our additional advanced parameter modules, this solution fits even the highest level of critical care environments. benevision-n1-fig2-3-pc Companion Mode Connect with N-Series host monitor via cable connection to N1 dock and have the ability for dual-screen monitoring and bi-directional control of the bedside monitor - expanding slot space for more advanced parameters and enhanced ICU workflow. Patient-Centric Data Collection When connected to a bedside patient monitor, advanced parameters collected from the host monitor such as AG and BIS, etc., will also be stored in N1 with trend data and alarm events reviewable even when it is disconnected.

With state-of-the-art screen technology, BeneVision N Series patient monitors deliver clear, multi-color, wide-format displays for users to capture and review information at a glance. With multi-touch operation, users can control the monitor and review patient data quickly and easily. BeneVision N Series provides the world's best monitoring technologies for you, with new applications being developed. Perfect hemodynamic monitoring solution, not only provides a variety of measurement methods, ICG, PiCCO, ScvO2, C.O., but also provides comprehensive analysis tool – HemoSight™. HemoSight™ focuses on hemodynamic treatment process, and provides appropriate tools for each stage. Advanced modular regional tissue oxygenation measurement -- INVOS rSO2. Volumetric capnography & metabolic measurement help to evaluate the adequacy of ventilation and determine the ventilator setting effectively, and improve the safety of weaning and extubation. Powerful Clinical Assistive Applications (CAAs) to support efficient decision making when time is critical. Each CAA focuses on major clinical workflow challenges that individual departments face. Solutions optimized for each point of care At every point of care, such as ICU, CCU, NICU, OR, PACU, ER, BeneVision N Series patient monitors always provide a suitable solution to meet your clinical needs for monitoring your patient's status anywhere, anytime, even on your way through mobile devices. With excellent transport solution, BeneVision N Series patient monitor brings a smooth workflow and safe data management through the entire care process. BeneVision takes less time to operate, and helps you understand the patient's variables quickly. With HL7,BeneVision N Series patient monitors can directly connect to the hospital clinical network.BeneVision N12 is capable of monitoring multiple parameters simultaneously both at bedside and during transport. IT structure designed for seamless connectivity Mindray patient monitoring system incorporates extensive network adaptability to integrate with the hospital's current network infrastructure, ensuring that critical data is on hand for clinical decision making - and is integrated with the patient record. Mindray's central station and eGateway further enhances the connectivity of BeneVision to your clinical world. Bedside devices data and other clinical systems data are shared to support your diagnosis and clinical decisions.

Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating design, benchmarking ease of use, confidence-maximizing innovations and workflow-transforming interoperability, BeneVision N22/N19 is creating tomorrow’s monitoring perspective today. The design excellence of BeneVision N22/N19 has great originality to lead your perspective. A seamless outlook optimizes your monitoring experience with super large touchscreen, cool rotatable landscape & portrait layout, ultra slim main unit as well as plug-n-play modules. An ingenious user interface including multi-window flat menus, infographic alarm indications and online user guide offers extremely intuitive patient data and ultimate ease-of-use, while auto screen brightness always keeps patient in mind. Benefitting from cutting-edge clinical measurements, such as rSO2, ICG, PiCCO, AG, RM, BIS, NMT, and state-of-art clinical decision support tools, such as HemoSightTM, ST GraphicTM, DSA, BeneVision N22/N19 enhances your clinical confidence to the max and helps you make easier and faster clinical decisions. The connectivity capabilities of BeneVision N22/N19 fit seamlessly into your clinical workflow for paperless future. Revolutionary iView clinical informatics workstation brings all intelligence (PACS, LIS, EMR, etc) on screen at point of care for one-stop diagnosis. Industry-leading BeneLink integrates all bedside devices to the monitor realtimely and facilitates centralized data management.

INTENDED USE The Finecare™ HbA1c Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of Hemoglobin A1c in human blood. The test is used as an aid to monitor long-term glycemic status in patients with diabetes mellitus. STORAGE AND STABILITY 1. Store the test kit at 4℃~30℃ up to the expiration date printed on package. 2. If removed from refrigerator, allow the test kit for 30 minutes to return to room temperature before testing. 3. Do not remove the Test Cartridge from the pouch until use. The Test Cartridge should be used within 1 hour once opened.

Finecare™ 2019-nCoV Antigen Test Antigen testing indicates the active infection of 2019-nCoV. For areas with limited PCR resources, antigen testing can be used for aiding in the diagnosis of COVID-19 suspect patients.

Intended Use Scrub Typhus (Tsutsugamushi) IgM & IgG Card is a rapid solid phase immuno-chromatographic assay for the qualitative and differential detection of IgM and IgG antibodies to Scrub Typhus antibodies in human serum / plasma. This test is for in vitro diagnostic use only and is intended as an aid to early diagnosis of Scrub Typhus infection in patient with clinical symptoms. Salient Features Rapid ,visual and qualitative Immunoassay. Differential detection of IgM & IgG antiobodies to Scrub Typhus (Tsutsugamushi) in Human Serum / Plasma. Based on Immunochromatography Technique. See through device for easy interpretation of results. Results with in 20 minutes Shelf life 30 months at 2-30°C Convenient pack size: 20T & 50T. Sensitivity & Specificity: 100% (In house Evaluation)

Intended Use Covid 19 Ag Card Test is designed for in vitro qualitative detection of Covid 19 antigen in human nasopharyngeal, nasal swab specimens. The kit is intended for professional use and as a screening test and is an aid in early diagnosis of SARS COV-2 infection in patients with clinical symptoms. Salient Features Rapid Visual Test for the Qualitative Detection of Covid-19 (SARS-COV-2) antigen in Human nasopharyngeal and nasal swab specimens. Based on Sandwich Immunoassay principle. Results within 20 minutes. Single step test procedure. Evaluated & Validated by ICMR Centre ; Sensitivity -91.5% (<30 CT) & Specificity -100% against RT-PCR. Long Shelf life:30 months at 2-30° C. No Instruments required. Convenient pack sizes . 10T,25T,50T,100T & 200T.

Intended Use Dengue NS1 Antigen self-test is a rapid solid phase immune-chromatographic test for the qualitative detection of Dengue NS1 Ag in human whole blood/serum/plasma. This test is intended to be for home use with self-collected whole blood specimens from individuals aged 18 years or above( or collected by adults for individuals below 18 years of age) as well as for professional use with venous Whole blood/Serum/Plasma samples. This test is for in-vitro diagnostic use only & is designed as an aid in the early diagnosis of dengue infection patients with clinical symptoms. Salient Features Rapid, Visual, Home test for qualitative detection of Dengue NS1 antigen detection in human whole blood/serum/plasma. Finger prick sample can be used. Single test pack. All material to perform the test & its disposal are provided with the kit. Based on Sandwich principle.\ Detection of Dengue in Seronegative stage i.e. from Day 1 of fever. Detection of all 4 serotypes of dengue virus. Reliable diagnosis of both primary and secondary infection. 100% Sensitivity & 100 % Specificity. Shelf life: 30 month at 2-30 °C.

Intended Use Scrub Typhus IgM/IgG/IgA Card is a rapid solid phase immuno-chromatographic assay for the qualitative detection of IgM, IgG& IgA antibodies to Scrub Typhus in human serum / plasma / whole blood. This test is for in vitro diagnostic use only and is intended as an aid to early diagnosis of Scrub Typhus infection in patient with clinical symptoms. Salient Features Finger prick, rapid, visual and qualitative Immunoassay. Detection of all antibodies (IgM, IgG, IgA) to Scrub Typhus (Tsutsugamushi) in Whole blood/serum / plasma. Based on Immunochromatography Technique. See through device for easy interpretation of results. Results within 20 minutes Shelf life 30 months at 2-30°C Convenient pack size: 25 T. Sensitivity & Specificity: 100%